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Abstract. Mental retardation is correlated in approximately 
0.4% of cases with the presence of a small supernumerary 
marker chromosome (sSMc). However, here we report a 
case of a carrier of a heterochromatic harmless sSMc with 
fragile X syndrome (Fra X). in approximately 2% of sSMc 
cases, similar heterochromatic sSMc were observed in a clini-
cally abnormal carriers. in a subset of such cases, uniparental 
disomy (uPd) of the corresponding sister chromosomes was 
shown to be the cause of mental retardation. For the remainder 
of the cases, including the present one, the sSMc was just a 
random finding not related to the clinical phenotype. Thus, it 
is proposed to test patients with heterochromatic sSMc and 
mental retardation of unclear cause as follows: i) exclude 
uPd, ii) test for Fra X as it is a major cause of inherited 
mental retardation, and iii) perform chip-based assays or tests 
for special genetic diseases according to the phenotype. in 
any case, the diagnosis of a cytogenetic aberration such as an 
sSMc should not automatically be considered the resolution 
of a clinical case. 
Introduction 
Small supernumerary marker chromosomes (sSMc) are a 
morphologically heterogeneous group of structurally abnormal 
chromosomes, including various types of inverted duplicated 
chromosomes, minute chromosomes and ring chromosomes. 
sSMc can only be characterized unambiguously by molecular 
(cyto)genetics and are equal in size or smaller than a chromo-
some 20 of the same metaphase spread (1). The phenotypes 
associated with the presence of an sSMc vary from normal to 
severely abnormal (2). It is particularly difficult to determine 
clinical outcome in pre-natally ascertained cases with small 
markers that are de novo. For such cases with sSMc, the risk 
of an abnormal phenotype is 26-30% (2). recently, progress 
for genotype-phenotype correlation in sSMc was achieved 
by summarizing the available sSMc cases in a database (2,3). 
Thus, the presence of centromere-near euchromatin on an 
sSMc may, but must not, be correlated with an adverse prog-
nosis. However, if there is no euchromatin on the sSMc and 
no uniparental disomy (uPd) in the sister chromosomes of 
the sSMc can be detected, in general the sSMc is regarded 
as harmless (2). nonetheless, 63 cases with heterochromatic 
sSMc were reported by liehr (3), in which the cause of 
clinical abnormalities in the corresponding patient was not 
clear (Tables i and ii). in approximately 40% of these patients, 
uPd was tested (Tables i and ii) and led to a diagnosis of an 
imprinting disorder or the activation of a recessive gene. This 
was the case in 18 of these cases overall (Table i). However, 
after the exclusion of uPd, the cause of clinical problems such 
as mental retardation remained unclear in 72% of heterochro-
matic sSMc cases (Table ii). 
Fragile X syndrome (Fra X) is a major cause of inherited 
mental retardation affecting 1 in 2,500 individuals. For Fra X, 
cognitive dysfunction and/or impairment and various physical 
abnormalities, including a characteristic long, narrow face, 
large ears, close interoccular distance, flat feet and occasion-
ally hyperextensible joints, are typical. in addition, speech 
and language skills are severely affected in males with Fra X, 
who often exhibit autistic-like behavior. at the cytogenetic 
level, chromosome spreads derived from Fra X patients grown 
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under specific cell culture conditions show a gap or break 
on the X-chromosome in the fragile site FraXa at Xq27.3. 
on the molecular level, the fragile site is caused by a cgg 
triplet expansion (dynamic mutation) to more than 200 repeats 
located within the 5' untranslated region of the Fragile X 
Mental retardation 1 (FMr1) gene. due to X-inactivation, 
females with the full mutation normally show a milder or 
no phenotype. normal individuals carry 6-54 cgg repeats, 
while alleles with 55-200 triplets are considered ‘pre-mutated’ 
genes. The pre-mutation is unstable and commonly expands 
during intergenerational transmission. notably, the repeat is 
more stable during male transmission, and the full mutation is 
inherited only from the mother (4).
Here, we report the case of a 2-year-old boy with mental 
retardation, in which the diagnosis of a Fra X was slightly 
delayed by the knowledge that he was carrier of a heterochro-
matic sSMc; we also summarize possibly comparable cases 
from the literature.
Materials and methods 
Case report. we treated a 2.25-year-old male patient (P1), 
who was the first child of healthy and non-consanguineous 
parents (Fig. 1). The patient showed a combined develop-
mental delay (particularly in speech) of a to date unknown 
genesis. The pregnancy and birth proceeded well. The boy 
had an increased head circumference (>97th percentile), 
weight between the 90th and 95th percentiles and height in 
the 75th percentile. The facial appearance showed a promi-
nent forehead, a long face with a pointed chin, red cheeks, a 
thin upper lip, sparse hair growth with a receding hairline and 
pasty skin. The aunt of the patient (the sister of the mother) 
had two children (boy, P2; girl, P3), both with developmental 
delay of unclear genesis. it was suggested that an uncle of the 
mother (the brother of her mother) had down syndrome, but 
this had never been tested cytogenetically (Fig. 1). at the time 
of the initial consultation, the mother of P1 was pregnant and 
in the 10th week of gestation. 
Cytogenetics and molecular cytogenetics. For karyotypic 
investigations, metaphase chromosomes were obtained 
according to standard procedures using PHa stimulated 72-h 
cultures of peripheral blood lymphocytes from P1, his parents 
and his maternal grandparents. The analysis of gTg-banded 
chromosomes was carried out according to standard proce-
dures. To clarify the origin and genetic content of the detected 
sSMC, centromere-specific multicolor fluorescence in situ 
hybridization (FiSH) was carried out as previously reported in 
the acrocentric chromosome directed (acrocenM-FiSH) version 
Table i. Heterochromatic sSMc cases reported in the literature as having a uniparental disomy.
case no. in ref. 3 karyotype uniparental disomy
12-o-p11/1-1 mos 47,XX,+min(12)(:p11→q11:)/46,XX mat 12
14-w-q11.1/3-1 mos 47,Xy,+min(14)(pter→q11.1:)/46,Xy mat 14
14-w-q11.1/2-1 mos 47,XX,+inv dup(14)(q11)/46,XX pat 14
15-P-q11/1-2 mos 47,Xy,+inv dup(15)(q11)/46,Xy mat 15
15-P-q11/1-4 47,XX,+inv dup(15)(q11) mat 15
15-P-q11/1-5 mos 47,Xy,+inv dup(15)(q11)/46,Xy mat 15
15-P-q11/1-13 47,Xy,+inv dup(15)(q11) mat 15
15-P-q11.1/1-1 mos 47,Xy,+min(15)(pter→q11.1:)/46,Xy mat 15
15-P-q11.1/2-2 mos 47,XX,+inv dup(15)(q11.1)/46,XX mat 15
15-P-q11.1/2-4 mos 47,+inv dup(15)(q11.1)/46 mat 15
15-P-q11.1/2-5 mos 47,+inv dup(15)(q11.1)/46 mat 15
15-P-q11.1/2-6 mos 47,Xy,+inv dup(15)(q11.1)/46,Xy mat 15
22-u-40 mos 47,Xy,+inv dup(22)(q11.1)/46,Xy mat 15
15-a-q11/1-1 mos 47,Xy,+inv dup(15)(q11)/46,Xy pat 15
15-a-q11/1-2 47,Xy,+inv dup(15)(q11) pat 15
16-w-p11.1/3-1 mos 47,Xy,+r(16)(::p11.1→q11.2::)/46,Xy mat 16
20-w-p11.1/2-1 47,Xy,+min(20)(:p11.1→q11.1:) mat 20
22-o-q11/2-1 mos 47,XX,+min(22)(:p11.1→q11:)/46,XX mat 22
Mat, maternal; Pat, paternal.
Figure 1. Pedigree of the index patient P1 and his family.
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(5) and towards the centromere-near region of chromosome 22 
(subcenM-FiSH) (2).
Molecular genetics. a microsatellite analysis to exclude uPd 
of chromosome 22 was carried out as previously reported 
(6) using the following microsatellite markers: d22S446*, 
d22S1167, d22S689, d22S685*, d22S683, d22S1158*, 
d22S1147, d22S422, d22S445 and d22S1142. Those marked 
with asterisks were informative normal in P1.
Fra X diagnostics was carried out according to standard 
procedures at the Middle german Practice group (dresden, 
germany). The individuals tested were P1, his parents and 
maternal grandparents, as well as P2, P3 and their mother. 
Results 
cytogenetics and molecular cytogenetics revealed the pres-
ence of an sSMc derived from chromosome 22 in P1, his 
Table ii. Heterochromatic sSMc cases with clinical symptoms reported in the literature as having no uniparental disomy (uPd) 
or not having been tested for uPd.
case no. in ref. 3 age at diagnosis (years) karyotype uPd tested
01-w-p11.1/1-1 8 mos 47,XX,+min(1)(:p11.1→q12:) -
01-w-p11.1/1-2 2 mos 47,XX,+min(1)(:p11.1→q12:) -
01-w-p11/2-1 pre-natal mos 47,Xy,+r(1)(::p11→q11::)/46,Xy -
01-w-p11/3-1 2 mos 47,XX,+min(1)(:p11→q11:)/46,XX -
02-w-p11.1/3-1 41 47,Xy,+min(2)(:p11.1→q11.1:) +
03-w-p10/1-1 1 mos 47,XX,+r(3)(::p10→q11::)/46,XX -
04-w-p11/1-1 1 mos 47,XX,+min(4)(:p11→q11:)/46,XX -
04-w-p11/1-2 3 mos 47,Xy,+min(4)(:p11→q11:)/46,Xy +
05/19-w-1 child mos 47,Xy,+min(1)(:p11→q11:) or -
  min(5)(:p11→q11.1:) or min(19)(:p11→q11)
07-w-p11.1/1-1 3 mos 47,XX,+min(7)(:p11.1→q11.1:)/46,XX +
08-w-p11/1-1 3 mos 47,Xy,+r(8)(::p11→q11::)/46,Xy +
08-w-p11/1-2 29 mos 47,Xy,+r(8)(::p11→q11::)/46,Xy -
09-w-p11.1/1-1 9 mos 47,XX,+min(9)(:p11.1→q12:)/46,XX -
12-w-p11.1/3-1 10 mos 47,XX,+min(12)(:p11.1→q11:)/46,XX -
13/21-w-q10/1-1 post-natal 47,+inv dup(13or21)(q10) -
13/21-w-q10/1-2 post-natal 47,+inv dup(13or21)(q10) -
13/21-w-q10/1-3 15 47,Xy,+inv dup(13or21)(q10) -
13/21-w-q11/1-1 0.75 47,Xy,+inv dup(13or21)(q10) -
13/21-w-q11/1-2 pre-natal mos 47,Xy,+inv dup(13or21)(q10)/46,Xy -
14-w-q10/1-1 pre-natal 47,Xy,+inv dup(14)(q10) -
14-w-q10/1-2 pre-natal 47,Xy,+inv dup(14)(q10) -
15-w-q11.1/1-1 6.5 mos 47,XX,+r(15)(::p11.1→q11.1::)/46,XX -
15-w-q11.1/2-1 post-natal mos 47,XX,+inv -
  dup(15)(pter→q11.1::q11.1→p11.1::)/46,XX
15-w-q11.1/3-1 newborn 47,Xy,+inv dup(15)(q11.1) +
15-w-q11.1/3-2 11 47,Xy,+inv dup(15)(q11.1) -
15-w-q11.1/3-3 9 47,XX,+inv dup(15)(q11.1) -
16-w-p11.1/1-1 2 mos 47,Xy,+min(16)(:p11.1→q11.1 or -
  q11.1→p11.1::p11.1→q11.2:)/46,Xy
16-w-p11.1/1-2 13 mos 47,Xy,+r(16)(::p11.1→q12::)/46,Xy -
20-w-p11.1/3-1 4 47,XX,+min(20)(:p11.1→q11.1:) +
22-o-q11.1/1-25a 2.25  47,Xy,+inv dup(22)(q11.1)mat +
22-w-q11/1-1 n.a. 47,+inv dup(22)(q11) -
22-w-q11/1-2 newborn  47,XX,+inv dup(22)(q11) -
22-w-q11/1-3 pre-natal mos 47,Xy,+inv dup(22)(q11)/46,Xy +
22-w-q11/1-4 11  48,XX,+inv dup(22)(q11)x2 -
22-w-q11.1/1-1 n.a. 47,Xy,+inv dup(22)(q11.1) -
aPresent case.
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mother and his maternal grandfather (Fig. 1). The sSMc was 
characterized as inv dup(22)(q11.1), and thus was considered 
to be exclusively heterochromatic. Subsequently, the presence 
of an iso-uPd of normal chromosome 22 in the index patient 
was excluded in P1. 
a re-evaluation of the pedigree and the clinical character-
istics of P1 prompted a molecular analysis of the FMr1-gene, 
typically altered in Fra X. This identified a characteristic 
expansion of the cgg-region (430-630 repeats), which is a 
so-called ‘full mutation’ for Fra X. The subsequent molecular 
genetic analysis of the mother of P1 showed 83 cgg repeats 
in the FMr1-gene, corresponding to a pre-mutation and 
carrier-status for Fra X. Further analysis also identified a pre-
mutation in the grandmother of P1 and in the mother of P2 
and P3. The latter had full mutations of Fra X syndrome. The 
current pregnancy of the mother of P1 was also studied in the 
14th week of gestation, and revealed a normal male karyotype 
without mutation or pre-mutation in the FMr1-gene (Fig. 1). 
Discussion
Even though the exclusion of Fra X should be one of the first 
steps in cases of mental retardation of unclear cause, the pres-
ence of sSMC in P1 first led us to investigate in the wrong 
direction. However, in the present case, the comprehensive 
clarification of the inheritance of sSMC and Fra X within the 
pedigree (Fig. 1) led to a risk assessment for the current preg-
nancy of the parents of P1. This was found to not be above the 
common risk, thus the pregnancy was continued and a healthy 
boy was born at term. 
a search of the literature for heterochromatic sSMc case 
reports similar to the one of patient P1 revealed 63 such 
cases (Tables i and ii). To date, 3,307 sSMc cases (excluding 
those detected in patients with Turner syndrome) have been 
reported. Thus, approximately 2% of cases having a hetero-
chromatic and harmless sSMc are nonetheless observed to 
be clinically abnormal. in a subset of such cases, uPd of 
the corresponding sister chromosomes may be found. For 
the remainder of the cases, including ours, the sSMc is just 
a random finding not related to the clinical phenotype. Thus, 
testing patients with heterochromatic sSMc and mental 
retardation of unclear cause should be carried out as follows: 
first, UPD is to be excluded, second, Fra X should be tested, 
then lastly array-cgH or tests for special genetic diseases 
according to the phenotype should be performed. in any case, 
the diagnosis of a cytogenetic aberration such as an sSMc 
should not automatically be considered the resolution of a 
clinical case. 
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